NYSE$PHR
Phreesia Inc · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Phreesia's revenue increased by 45% year-over-year, with an average revenue per provider client up by 10%.
Phreesia announced its Fiscal Third Quarter 2022 results, reporting a 45% increase in revenue compared to the same period in the prior year. The company surpassed 100 million patient visits enabled by their platform during the previous twelve months. They are increasing their revenue outlook for fiscal year 2022 to $211 million.
- Revenue was $55.9 million, a 45% increase year-over-year.
- Average number of provider clients was 2,097, a 21% increase year-over-year.
- Average revenue per provider client was $19,299, a 10% increase year-over-year.
- Cash and cash equivalents totaled $400.4 million.
Headline financials
Revenue & EPS history
Phreesia · Revenue · Quarterly
$55.9M
Revenue by segment
Phreesia · $40.5M total across 2 segments · Q3 2022
- Subscription Services$24.4M+39.5%60.2%
- Payment Processing$16.1M+24.7%39.8%
Forward guidance
Phreesia is increasing its revenue outlook for Fiscal Year 2022 to $211 million. The Adjusted EBITDA outlook for Fiscal Year 2022 is negative $64 million. They expect revenue for Fiscal Year 2023 to grow in the range of 20 to 25% above Fiscal Year 2022 revenue.
Tailwinds
- Revenue outlook for Fiscal Year 2022 increased to $211 million.
- Revenue for Fiscal Year 2023 is expected to grow in the range of 20 to 25% above Fiscal Year 2022 revenue.
Headwinds
- Adjusted EBITDA outlook for Fiscal Year 2022 is negative $64 million.
- Continued acceleration in investments in Fiscal Year 2023 from Fiscal Year 2022 levels are anticipated.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q3 2022
-1.6%
Avg return
Earnings day
+2.5%
Avg return
5 days after
+2.0%
Avg return
30 days after
54%
15 / 28 earnings
Positive
+21.4%
Q2 2023
Best reaction
-26.3%
Q4 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -26.3% | -1.1% | — | |
| Q1 2027 | +2.3% | +13.3% | — | |
| Q3 2026 | -22.8% | -19.2% | -16.0% | |
| Q2 2026 | -9.8% | -18.8% | -25.4% | |
| Q1 2026 | -6.6% | -0.2% | +14.2% | |
| Q4 2025 | +6.9% | +14.6% | +1.1% | |
| Q3 2025 | +11.1% | +14.8% | +30.8% | |
| Q2 2025 | +7.9% | +0.5% | -6.8% | |
| Q1 2025 | -13.3% | -14.7% | -2.9% | |
| Q4 2024 | +1.7% | -0.7% | +1.0% | |
| Q3 2024 | +17.8% | +18.8% | +45.2% | |
| Q2 2024 | -21.2% | -27.1% | -39.1% | |
| Q1 2024 | +3.6% | +10.3% | +4.0% | |
| Q4 2023 | -13.5% | -10.0% | -5.7% | |
| Q3 2023 | +18.7% | +34.8% | +20.0% | |
| Q2 2023 | +21.4% | +28.2% | +4.9% | |
| Q1 2023 | +11.9% | +17.5% | +40.1% | |
| Q4 2022 | -11.9% | +1.3% | -23.6% | |
| Q3 2022 | -20.2% | -20.9% | -32.9% | |
| Q2 2022 | -12.4% | -6.2% | -15.4% | |
| Q1 2022 | +6.6% | +12.7% | +24.2% | |
| Q4 2021 | +2.5% | +8.4% | +3.3% | |
| Q3 2021 | +7.3% | +18.1% | +16.2% | |
| Q2 2021 | -3.2% | -9.2% | +3.5% | |
| Q1 2021 | -6.7% | -10.5% | -13.1% | |
| Q4 2020 | +4.2% | +18.1% | +30.6% | |
| Q3 2020 | -1.0% | -8.8% | -6.9% | |
| Q2 2020 | +0.2% | +7.3% | +1.2% | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro